You can view the latest news of the Company.
 
Select Another Company
 
Market Cap. (Rs.) 2726.58 Cr. P/BV 3.54 Book Value (Rs.) 328.98
52 Week High/Low (Rs.) 1610/621 FV/ML 10/1 P/E(X) 477.31
Bookclosure 12/09/2025 EPS (Rs.) 2.44 Div Yield (%) 0.09
Date and TimeHeadlines
14/03/2026 18:29 Tatva Chintan Pharm - Updates
14/03/2026 12:01 Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Analy...
14/03/2026 12:00 Tatva Chintan Pharm - Analysts/Institutional Investor Meet/Con. Cal...
11/03/2026 17:48 Tatva Chintan Pharm - Analysts/Institutional Investor Meet/Con. Cal...
25/02/2026 16:39 Tatva Chintan Pharm - Copy Of Report Filed With SEBI Under Regulati...
25/02/2026 16:38 Tatva Chintan Pharm - Updates
18/02/2026 16:38 Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Acqui...
18/02/2026 16:35 Tatva Chintan Pharm - Acquisition
11/02/2026 13:58 Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Analy...
11/02/2026 13:57 Tatva Chintan Pharm - Analysts/Institutional Investor Meet/Con. Cal...
09/02/2026 19:08 Tatva Chintan Pharm - Disclosure under SEBI Takeover Regulations
09/02/2026 17:13 Tatva Chintan Pharm - Updates
09/02/2026 17:11 Tatva Chintan Pharm - Filing Of Report Under Regulation 7(2) Of The...
29/01/2026 17:32 Tatva Chintan Pharm - Disclosure under SEBI Takeover Regulations
24/01/2026 11:19 Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Earni...
24/01/2026 11:18 Tatva Chintan Pharm - Analysts/Institutional Investor Meet/Con. Cal...
22/01/2026 10:37 Tatva Chintan Pharm - Copy of Newspaper Publication
21/01/2026 18:55 Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Analy...
21/01/2026 18:54 Tatva Chintan Pharm - Analysts/Institutional Investor Meet/Con. Cal...
21/01/2026 16:20 Tatva Chintan Pharm posts Q3 net profit of Rs 15.98 cr
12